Proto Labs, Inc.
PRLB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $501 | $504 | $488 | $488 |
| % Growth | -0.6% | 3.2% | 0.1% | – |
| Cost of Goods Sold | $278 | $282 | $273 | $265 |
| Gross Profit | $223 | $222 | $215 | $223 |
| % Margin | 44.6% | 44.1% | 44.1% | 45.6% |
| R&D Expenses | $41 | $40 | $38 | $44 |
| G&A Expenses | $64 | $66 | $68 | $0 |
| SG&A Expenses | $156 | $153 | $150 | $151 |
| Sales & Mktg Exp. | $92 | $88 | $83 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $198 | $194 | $189 | $195 |
| Operating Income | $25 | $28 | $27 | $28 |
| % Margin | 5.1% | 5.6% | 5.5% | 5.7% |
| Other Income/Exp. Net | -$1 | -$0 | -$125 | $12 |
| Pre-Tax Income | $25 | $28 | -$98 | $40 |
| Tax Expense | $8 | $11 | $6 | $7 |
| Net Income | $17 | $17 | -$103 | $33 |
| % Margin | 3.3% | 3.4% | -21.2% | 6.8% |
| EPS | 0.66 | 0.66 | -3.77 | 1.21 |
| % Growth | 0% | 117.5% | -411.6% | – |
| EPS Diluted | 0.66 | 0.66 | -3.77 | 1.21 |
| Weighted Avg Shares Out | 25 | 26 | 27 | 28 |
| Weighted Avg Shares Out Dil | 25 | 26 | 27 | 28 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $3 | $1 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $36 | $38 | $39 | $40 |
| EBITDA | $61 | $67 | -$58 | $81 |
| % Margin | 12.1% | 13.2% | -12% | 16.5% |